Psyched: Defense Dept.’s Ketamine Trial, Cybin’s Psilocybin, Metabolic Disorders, Reform Update And More
Defense Dept. Funds Ketamine Study For PTSD Treatment
Biotech Co. Branded Legacy Takes Major Step In CBD Market With New Acquisition
Biotech company Branded Legacy, Inc. (OTC.PK: BLEG) announced on Tuesday that it has acquired Florida-based MariJ Pharmaceuticals, Inc., which specializes in the certified organic mobile extraction and production of CBD from industrial hemp.
Latest Cannabis Hires: Three New CEOs And More
New Head Of National Hispanic Cannabis Council
Last month, the National Hispanic Cannabis Council voted to appoint Aaron Lopez, who has been serving as its interim executive director, to lead the organization. He replaces Antonio Valdez.
Cannabis Stock Gainers And Losers From December 4, 2023
GAINERS: Global Compliance (OTC:FUAPF) shares closed up 89.29% at $0.01 Indiva (OTC:NDVAF) shares closed up 38.93% at $0.08…
Michigan’s Green Boom: Report From The Second-Largest Cannabis Market In The U.S.
Explore Michigan's dynamic cannabis market growth, consumer trends, and the impact of its booming $6.4 billion industry.
Braxia Scientific’s Q2 2024: Cash Burn Over But Income Low, What’s Next For Psychedelics Company?
Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC Pink: BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30, 2023.
Numbers show:
Colorado Cannabis Giant Dives Into German Real Estate With Luxora
CBD of Denver launches Luxora Real Estate in Switzerland, targeting German cannabis market with innovative indoor-farming facilities.
What’s Going On With Canopy Growth Stock?
Canopy Growth Corporation (NASDAQ: CGC) shares are trading higher Monday, and the stock is up by more than 20% over the last five days.
What’s Going On With Tilray Brands Stock?
Tilray Brands, Inc. (NASDAQ: TLRY) shares are trading higher Monday, and the stock has gained more than 16% over the last five days.
Viridian Chart Of The Week: Which Companies Have The Most Upside And Downside From A DEA Announcement?
The MSOS ETF is now up 41.4% from the August 30, 2023, HHS rescheduling announcement, but it has fallen significantly from its peak gain of 85.0% in mid-September. The Viridian Chart of the Week looks at the potential upside and downside of the top 15 MSOs concerning a DEA announcement on rescheduling.